Wednesday, 1 December 2021

Tag Archives: CureVac

Germany takes 300m euro stake in firm developing vaccine

FRANKFURT: Germany will take a stake of about 23% in unlisted biotech firm CureVac by backing a 300 million euro ($337 million) capital increase to fund the company’s further development of a COVID-19 vaccine. The move was agreed with SAP co-founder Dietmar Hopp – who is an early backer and ...

Read More »